We help Support at Home-approved families find care.
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

Faster treatment looms for breast cancer

Posted
by DPS

New treatment for breast cancer developed partly in Perth could reduce a six-week course of tumour destroying radiation to a single half-hour session.

The aim of the intra-operative radiation therapy is to make treatment convenient and comfortable for women while retaining as much of the breast as possible. The therapy could be performed at any hospital or treatment centre which potentially reduces cost through the fewer visits required.

The director of the cancer division at Perth’s Sir Charles Gairdner Hospital, David Joseph, said that “the results are very encouraging. We’re getting better results and less toxicity for patients with this treatment”.

A total 2,232 women aged 45 and over with early stage breast cancer took part in the trial and were treated at 28 centres in nine countries across Australia, the United States, and Europe.

Michael Baum of University College, London, a co-leader in the research, said “these study results have the potential of changing the way we think about the primary management of early breast cancer”.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo